Search research articles
Contact Us
Filters
Showing results (31-40 of 95) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology and Therapeutics
|
December 7, 2020
Impact of Hepatic CYP3A4 Ontogeny Functions on Drug-Drug Interaction Risk in Pediatric Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case Study
Jennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
The Journal of Pharmacy and Pharmacology
|
May 25, 2019
An evaluation of cetuximab dosing strategies using pharmacokinetics and cost analysis
Kayode Ogungbenro, Alkesh Patel, Mark Saunders, et al.
Computer Methods and Programs in Biomedicine
|
February 13, 2007
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models
Ivelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 14, 2021
Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactions
Jennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 28, 2011
Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke
Andrew D Greenhalgh, Kayode Ogungbenro, Nancy J Rothwell, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 17, 2023
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models
Estelle Yau, Michael Gertz, Kayode Ogungbenro, et al.
British Journal of Clinical Pharmacology
|
July 17, 2021
Evaluation of area under the concentration curve adjusted by the terminal-phase as a metric to reduce the impact of variability in bioequivalence testing
Adam J Lucas, Kayode Ogungbenro, Shuying Yang, et al.
The Journal of Pharmacy and Pharmacology
|
June 28, 2017
Choosing an optimal input for an intravenous glucose tolerance test to aid parameter identification
Emma C Martin, James W T Yates, Kayode Ogungbenro, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 8, 2023
Investigation of simplified physiologically-based pharmacokinetic models in rat and human
Estelle Yau, Andrés Olivares-Morales, Kayode Ogungbenro, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 19, 2015
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist
Kayode Ogungbenro, Sharon Hulme, Nancy Rothwell, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 95) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology and Therapeutics
|
December 7, 2020
Impact of Hepatic CYP3A4 Ontogeny Functions on Drug-Drug Interaction Risk in Pediatric Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case Study
Jennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
The Journal of Pharmacy and Pharmacology
|
May 25, 2019
An evaluation of cetuximab dosing strategies using pharmacokinetics and cost analysis
Kayode Ogungbenro, Alkesh Patel, Mark Saunders, et al.
Computer Methods and Programs in Biomedicine
|
February 13, 2007
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models
Ivelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 14, 2021
Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactions
Jennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 28, 2011
Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke
Andrew D Greenhalgh, Kayode Ogungbenro, Nancy J Rothwell, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 17, 2023
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models
Estelle Yau, Michael Gertz, Kayode Ogungbenro, et al.
British Journal of Clinical Pharmacology
|
July 17, 2021
Evaluation of area under the concentration curve adjusted by the terminal-phase as a metric to reduce the impact of variability in bioequivalence testing
Adam J Lucas, Kayode Ogungbenro, Shuying Yang, et al.
The Journal of Pharmacy and Pharmacology
|
June 28, 2017
Choosing an optimal input for an intravenous glucose tolerance test to aid parameter identification
Emma C Martin, James W T Yates, Kayode Ogungbenro, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 8, 2023
Investigation of simplified physiologically-based pharmacokinetic models in rat and human
Estelle Yau, Andrés Olivares-Morales, Kayode Ogungbenro, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 19, 2015
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist
Kayode Ogungbenro, Sharon Hulme, Nancy Rothwell, et al.
Page
of 10